URI
65
5
CHRW
56
-3
KMI
67
-2
KMB
39
2
VMC
57
4
MAS
58
2
CFG
70
6
PEP
48
6
ADSK
70
2
DVN
21
3
HST
49
-9
KLAC
47
4
HBI
59
4
HCA
44
-2
EQT
57
-2
HPQ
63
6
ORCL
65
-2
AAP
24
6
UA
50
-9
BBY
46
10
URI
65
5
CHRW
56
-3
KMI
67
-2
KMB
39
2
VMC
57
4
MAS
58
2
CFG
70
6
PEP
48
6
ADSK
70
2
DVN
21
3
HST
49
-9
KLAC
47
4
HBI
59
4
HCA
44
-2
EQT
57
-2
HPQ
63
6
ORCL
65
-2
AAP
24
6
UA
50
-9
BBY
46
10
Financhill
Back

BridgeBio Pharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

BBIO
BridgeBio Pharma

Last Price:
23.44
Seasonality Move:
10.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

BridgeBio Pharma Price Quote

$23.44
+0.02 (+0.86%)
(Updated: November 23, 2024 at 5:26 AM ET)

BridgeBio Pharma Key Stats

Buy
57
BridgeBio Pharma (BBIO) is a Buy
Day range:
$22.47 - $23.65
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.61
P/B ratio:
0%
Volume:
2.1M
Avg. volume:
1.7M
1-year change:
-20.61%
Market cap:
$4.4B
Revenue:
$9.3M
EPS:
$-2.41

How Much Does BridgeBio Pharma Make?

Is BridgeBio Pharma Growing As A Company?

  • What Is BridgeBio Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.33%
  • What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BridgeBio Pharma Stock Price Performance

  • Did BridgeBio Pharma Stock Go Up Last Month?
    BridgeBio Pharma share price went down by -6.09% last month
  • Did BBIO's Share Price Rise Over The Last Year?
    BBIO share price fell by -20.61% over the past 1 year

What Is BridgeBio Pharma 52-Week High & Low?

BridgeBio Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BridgeBio Pharma?

  • How Much Debt Does BridgeBio Pharma Have?
    Total long term debt quarterly is $1.7B
  • How Much Cash Does BridgeBio Pharma Have?
    Cash and short term investments quarterly total is $266.3M
  • What Is BridgeBio Pharma’s Book Value Per Share?
    Book value per share is -6.51

Is BridgeBio Pharma Cash Flow Positive?

  • What Is BBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$450.2M
  • What Is BridgeBio Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $270M
  • What Is BridgeBio Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $64M

BridgeBio Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    BBIO return on invested capital is -80.46%
  • What Is BridgeBio Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -62.51%
  • What Is BBIO Return On Equity?
    ROE is a measure of profitability and is 0%

BridgeBio Pharma Earnings Date & Stock Price

BridgeBio Pharma Competitors

  • Who Are BridgeBio Pharma's Competitors?
    Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Bristol-Myers Squibb Co (BMY)
    • Pfizer Inc (PFE)
    • PTC Therapeutics Inc (PTCT)
    • Vertex Pharmaceuticals Inc (VRTX)

BridgeBio Pharma Dividend Yield

BridgeBio Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.14%
Revenue: -33.22% -19.2%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 46.89
Upside from Last Price: 100.2%

Major Shareholders

  • How many BBIO shares are owned by institutional investors?
    250.7M BBIO shares are owned by institutional investors
  • How many BBIO shares are owned by insiders?
    7.3M BBIO shares are owned by insiders